Drug Coverage In Exchange Plans Should Be On Par With Other "Essential Benefits," PhRMA Tells IoM
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA was among a number of stakeholders presenting comments Jan. 14 to the committee on criteria and methods for determining and updating what qualifies as "essential health benefits" in the exchange plans.
You may also be interested in...
HHS Essential Health Benefits Standards Must Reflect Cost Concerns – IoM
HHS must make controlling costs a key consideration as it develops and maintains the "essential health benefits" package that private insurers must adopt in plans offered to individuals and small businesses beginning in 2014, an Institute of Medicine expert committee recommends in a report released Oct. 7.
HHS Essential Health Benefits Standards Must Reflect Cost Concerns – IoM
HHS must make controlling costs a key consideration as it develops and maintains the "essential health benefits" package that private insurers must adopt in plans offered to individuals and small businesses beginning in 2014, an Institute of Medicine expert committee recommends in a report released Oct. 7.
HHS Essential Health Benefits Standards Must Reflect Cost Concerns - IoM
Institute of Medicine releases recommendations on the development of EHB, under which comparative effectiveness research would play a key role in future updates to the EHB package.